GENOMICS WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE)
|
|
- Lily York
- 6 years ago
- Views:
Transcription
1 TriMark Publications May 2008 Volume: TMRGEN GENOMICS WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers
2 TABLE OF CONTENTS 1. Introduction Statement of Report Objectives and Goals of Study Methodology Executive Summary Market Drivers Market Restraints Market Size and Growth Projections What Is a Gene? Gene Expression Genetic Variability The Human Genome Project (HGP) Gene Databases Sequencing and Resequencing RNA Interference (RNAi) DNA Tags Genomics Technology and Industry The Development of a Genomics Market Market Size and Growth Projections The U.S. Genomics Market DNA Microarray Technology Biochips Photolithography Instrumentation for DNA Microarray Analysis Lab-on-a-Chip DNA Microarrays Applications of DNA Microarrays DNA Sequence Analysis Gene Expression Analysis Effect of DNA Sequence and Gene Expression Monitoring on the Genomics Market Bioinformatics Functional Genomics Gene Knockdown Protein Protein Interactions Bioinformatics Strategies of Functional Genomics Companies Frontiers in Functional Genomics Comparative Genomics Pharmacogenomics Proteomics Structural Genomics Disease Targets Paradigm Shift in Drug Development: The Evolution of Targeted Therapies Personalized Warfarin Therapy How Genomics Is Revolutionizing Healthcare Pharmaceutical Applications Diagnostics Toxicogenomics The Market for DNA Microarrays DNA Chip Technology Competition Expression Profiling Gene Sequencing Advantages of Chip Array Technology TriMark Publications, LLC. All rights reserved. 2
3 3.8 Applied Markets for Genomics Genomics and the Pharmaceutical Companies Cancer Markets Agricultural Markets Plant Genomics Food Processing Animal Husbandry Proprietary Applications and Patents What is Patentable? Patents and Litigation Business Analysis Facilitation and Capitalization of the Convergence of Gene Expression Analysis and Proteomics Competition Market Opportunities for Functional Genomics Metabolic Profiling Anti-Fungal Targets Nutrition Crop Production The Highly-Competitive Nature of the Genomics Industry First-Generation Biotech Second-Generation Genomics Companies Next-Generation DNA Sequencing Companies Strategic Alliances Genomics Company Profiles Affymetrix, Inc Agendia Agilent Technologies, Inc Applied Biosystems Group Bayer, AG Biotage Caliper Life Sciences Celera Group Cepheid CLC bio Clinical Data, Inc CuraGen Corporation Cytocell Ltd diadexus, Inc Enzo Biochem, Inc Exiqon A/S GE Healthcare Gene Link, Inc Gene Logic, Inc Genentech, Inc Genisphere, Inc Genomatix Software, Inc Genomic Solutions, Inc Gen-Probe, Inc Harvard Bioscience, Inc Helicos Biosciences Corporation Human Genome Sciences, Inc Illumina, Inc Interleukin Genetics TriMark Publications, LLC. All rights reserved. 3
4 6.30 LI-COR Biosciences Luminex Corporation Millennium Pharmaceuticals, Inc Monogram Biosciences, Inc Motorola, Inc MWG Biotech AG Myriad Genetics, Inc Nanogen, Inc Nuvelo, Inc Orchid Cellmark Pacific Biosciences, Inc QIAGEN, Inc Roche Diagnostics Sequenom, Inc Third Wave Technologies, Inc Verenium Corporation Visigen Technologies, Inc Brief Profiles of Companies Marketing Personalized Genomics Products andMe, Inc decode Genetics, Inc Navigenics, Inc Brief Profiles of Other Selected Genomics Firms Aber Genomic Computing Spotfire, Inc Genomics Challenges and Growth Factors Market Drivers Product Pipeline: Need for More Drug Candidates Need for Increased Research and Development Productivity A Genomics Market Bottleneck Bioinformatics Strategic Recommendations Market Opportunities More Comprehensive Tools Are Needed Resolving Bottlenecks in Functional Genomics Market Key Trends of Recent Mergers and Acquisition Deals Chemogenomics Pharmacogenomics Biomarkers Additional Genomics Market Opportunities Bioinformatics Types of Data and Bioinformatics Applications Validated Core Modeling Technology Broad Applicability Data Management Compliant with Industry Standards Open Architecture Ease of Use Increased Access Functions of Informatics Software Data Management Transformation of Data into Knowledge Collaboration Among Researchers Interface for Online Data Sources Target Markets for Informatics Software Pharmaceutical Companies Biotechnology Companies Academic and Government Research Institutions TriMark Publications, LLC. All rights reserved. 4
5 8.3.4 Agricultural, Environmental and Industrial Biotechnology Companies Products of Bioinformatics Sequences and Structure of Genes and Proteins D Molecular Structures Genome Structures and Functions Bibliographic Data Bioinformatics Processes Informatics Tools and Functionalities Sequence to Structure Lead Identification and Optimization Development and Formulation Improving Materials and Processes in the Chemicals Industry Other Materials-Based Industries Role of Bioinformatics in the Value Chain Bioinformatics Market Segments Database Hardware Software Bioinformatics Services Bioinformatics Business Models Changing Business Models Selected Business Strategies 157 Glossary 159 INDEX OF FIGURES Figure 2.1: Major Areas of Functional Genomics and Their Relationship to Bioinformatics and Industry 36 Figure 8.1: Role of Bioinformatics in the Biotechnology Value Chain 154 INDEX OF TABLES Table 2.1: Genomics Sector Global Market Size, 2001 to Table 2.2: Companies Marketing DNA Microarray Software 19 Table 2.3: Selected Competitors in the DNA Microarray Market 20 Table 2.4: Companies Offering DNA Sequencing Products 24 Table 2.5: Competitors in the SNP-Genotyping Segment 26 Table 2.6: Companies that Market MAQC-tested Gene Expression Microarrays 30 Table 2.7: Worldwide Market for Bioinformatics, 2005 to Table 2.8: Selected Companies Marketing New Functional Genomics Tools 38 Table 3.1: Genomics Pharmaceutical Market Sector Leaders and Promising Newcomers 45 Table 3.2: Summary of Assays for HIV Viral Load Testing 47 Table 3.3: Global Market for HIV Diagnostic Testing, 2000 to Table 3.4: Summary of Molecular Diagnostics Testing 49 Table 3.5: Global Market for Molecular Diagnostics Testing, 2000 to Table 3.6: U.S. Market for Molecular Diagnostics Testing, 2004 to Table 3.7: Applied Markets for Genomics 52 Table 3.8: Competitors in the Field of Identity Genomics Testing 53 Table 3.9: Opportunities for Molecular-Targeting Therapeutics for Cancer 54 Table 3.10: Emerging Companies in the Anti-Cancer Sector 54 Table 8.1: Data Source and Bioinformatic Investigations 147 Table 8.2: Bioinformatics Activities, Subactivities and Key Players TriMark Publications, LLC. All rights reserved. 5
6 1. Introduction 1.1 Statement of Report The purpose of this report is to describe the specific market segment of the biotechnology market sector called genomics. This sector includes all of the generally accepted activities that are currently used today for analyzing genetic codes in DNA and applying the resultant analyses to the formulation of new products in pharmaceuticals, agriculture, diagnostics and other areas marketing biological materials. This analysis presents an overview of the genomics market with the latest information regarding emerging new products and industry trends. It will not only quantify, but also qualify, the genomics segments as an area of research, product development and investment. Forecasts of the genomics market and an analysis of products in the worldwide biotechnology and pharmaceutical markets will provide a basis for understanding the significance of past developments and future possibilities within this exciting new market category. 1.2 Objectives and Goals of Study The aim of this study is to provide in-depth information on the developing market for genomics products and services. The report will include detailed market analyses and discussions of industry trends in order to assess the impact of genomics on the current and emerging pharmaceutical and diagnostic markets. Forecasts and trends were developed from interviews with industry sources, as well as from an assessment of available and emerging technologies. This review also focuses on the efforts of biotechnology companies and pharmaceutical firms to incorporate genomics technologies into their corporate strategies. Company profiles have been compiled from annual reports, investment analysis summaries and interviews with individuals from various companies and organizations involved with the industry. Profiled companies include Affymetrix, Agilent Technologies, Applied Biosystems, Clinical Data, Verenium and many others. This analysis includes: Accurate and up-to-date R&D information from the major biotech companies with an interest in the genomics market. Identification of the unmet need in current genomics development markets and the extent to which current technologies meet such needs. In-depth, comparative analysis of individual genomic products. Profiles of current research developments that will impact the genomics market and identification of the future direction of innovative research. Future sales potential of the genomics market. 1.3 Methodology This study is based on interviews with sales and marketing professionals of companies in the genomics market. They were queried, some several times, about their companies products and marketing strategies as well as their overall thoughts about their industry segment. Information was also obtained from interviews with founders, CEOs and vice presidents of some of the companies discussed in the report. Descriptions of the hospital laboratories and nearby patient facilities were derived from interviews with laboratory directors and medical technologists in these areas. Sources of information for the study were trade association publications and meetings, product brochures and catalogs, and company literature. Where the companies under discussion were publicly held, an examination of the annual reports, 10k filings and financial reports were used as the basis of the data reported. Important data sources include the Health for All Database of the World Health Organization, data published by the statistical office of the European Commission (Eurostat), as well as various health data from the United Nations and the Organisation for Economic Co-operation and Development. Where possible and practicable, the most recent data available have been used. The author of this report is a Ph.D. in biochemistry with decades of experience in science writing and as a medical industry analyst. He has been a senior director of several large regional and national clinical testing laboratories. The senior editor is a doctoral level clinical scientist. He has over thirty years of experience in laboratory testing and instrument and reagent development technology, as well as extensive experience in senior level positions in biotech 2008 TriMark Publications, LLC. All rights reserved. 6
7 and medical service companies. The editor of the report has a Ph.D. in biophysics and has worked as a research assistant professor at the University of Missouri. Some of the statistical information was taken from Biotechnology Associates databases and from TriMark s private data stores. The information set forth in this study was obtained from sources that we believe to be reliable, but we do not guarantee the accuracy, adequacy or completeness of any information, omission or for the results obtained by the use of such information. Key information from the business literature was used as a basis to conduct dialogue with and obtain expert opinion from market professionals with regard to commercial potential and market sizes. Senior managers from major company players were interviewed for part of the information in this study. Primary Sources TriMark collects information from hundreds of Database Tables and many comprehensive multi-client research projects and Sector Snapshots that we publish annually. We extract relevant data and analytics from TriMark s research of the past three years as part of this data collection. We also extract qualified data feeds from e-questionnaire responses and primary research responses for this compilation. Secondary Sources TriMark uses research publications, journals, magazines, newspapers, newsletters, industry reports, investment research reports, trade and industry association reports, government-affiliated trade releases, and other published information as part of our secondary research materials. The information is then analyzed and translated by the Industry Research Group into a TriMark study. The Editorial Group reviews the complete package with product and market forecasts, critical industry trends, threats and opportunities, competitive strategies and market share determinations. The report conclusions are verified through intensive interviewing of top-ranking companies in the industry. TriMark Publications Report Research and Data Acquisition Structure The general sequence of research and analysis activity prior to the publication of every report includes the following items: Completing an extensive secondary research effort on a an important market sector, including gathering all relevant information from corporate reporting, publicly-available databases, proprietary databases, direct meetings and personal interviews with key personnel. Formulating a study outline with the assigned writer, including these important items: Market and product segment grouping and evaluating their relative significance. Key competitors evaluations, including their relative positions in the business and other relevant facts to prioritize diligence levels and assist in designing a primary research strategy. End-user research to evaluate analytical significance in market estimation. Supply chain research and analysis to identify any factors affecting the market. New technology platforms and cutting-edge applications. Identifying the key technology and market trends that drive or affect these markets. Assessing the regional significance for each product and market segment for proper emphasis of further regional/national primary and secondary research. Launching a combination of primary research activities including two levels of questionnaires, executivedirect focused, company-specific, and region-specific communications to qualified and experienced senior executives worldwide TriMark Publications, LLC. All rights reserved. 7
8 Completing a confirmatory primary research assessment of the report s findings with the assistance of Expert Panel Partners from the industry being analyzed. 1.4 Executive Summary Genomics is transforming the pharmaceutical industry. Companies are moving from drug discovery and development based on medicinal chemistry to the design of drugs based on information provided by genomics. Virtually all of the major pharmaceutical houses have either formed partnerships with genomics firms that began to emerge in the early 1990s or have created in-house genomics divisions. The market for genetic data and technology is projected to be worth hundreds of billions of dollars within the next decade. Products provided by genomics firms include databases, specialized proprietary software that can be used to search the databases, DNA biochips (also called the DNA microarrays or DNA chips), which are typically a glass wafer containing nucleic acid samples used in genomic analysis, and many other novel kits and technologies for genetic analysis. The reason for this rapid interest in genomics is that genomics allows greater efficiency in identifying therapeutic targets by determining in a single analysis a plethora of candidate genes which may contribute to the onset of disease. By measuring the abundance of certain genes or sets of genes in response to a particular therapy or in a particular disease model, scientists can identify the mechanisms by which these genes are responsible for the creation and control of the disease process, and possible technologies that can be used to inhibit the genes Market Drivers Increased pressure for pharmaceutical pipeline development. Need for reduced cost for pharmaceutical discovery. Need to reduce the time required for drug discovery and development due to the significant number of upcoming patent expirations. Expansion of knowledge from the human genome. New products for agriculture. New products for the biotechnology industry. Proliferation of targets has shifted the drug discovery bottleneck from the identification of new points of disease intervention to the discovery and development of safe and effective drugs Market Restraints Low rates of drug discovery success. Competition between genomic companies and pharmaceutical companies. Lack of public acceptance of genetically-engineered consumer products. Many traditional biotechnology companies are shifting some of their focus downstream from genomics to drug discovery Market Size and Growth Projections Major new technologies will be developed over the next few years, and recently-developed technologies will be more universally and successfully applied. These developments constitute the discovery phase, which is only the first phase of evolution in this field. Those companies that most quickly use functional studies to establish possession of critical genomics-related targets and therapeutics will have an important advantage in the next phase, the development phase. The information and analyses presented here provide an important asset in decision making for managers involved in business development, marketing, market research, product development, mergers and acquisitions, licensing, business management, investment banking and deal creation, as well as for consultants to the pharmaceutical and biotechnology industry. The study provides a comprehensive analysis of the current markets for genomics-based products, services and applications TriMark Publications, LLC. All rights reserved. 8
9 Overview of Genomics Within the genomics industry, companies and research can be divided into three areas: Sequencing the genome. Functional genomics, which is focused on finding the functions of the genes. Information systems, which develops the software tools necessary for managing and summarizing the tremendous amount of data associated with genomic analysis. For each area, different technology is generated and, thus, a different intellectual property strategy is deployed. Often, companies participate in one or more of these areas, and should pursue a hybrid strategy. The Impact of Genomics The R&D process has experienced a fundamental change fueled by the revolution in genomics and the sequencing of the human genome. Genomics has resulted in the identification of many new potential disease targets, against which chemical compounds can be evaluated. This breakthrough effectively shifts the drug discovery bottleneck from biology to chemistry, as the need for effective target identification and validation has been eclipsed by the challenge of discovering and developing viable preclinical and clinical candidates. The discovery of new potential drug targets fuels the demand for collaborative relationships between companies with lead generation technology and the companies with medicinal chemistry expertise to develop promising leads into solid therapeutic candidates. 1.5 What Is a Gene? A genome is the entire set of hereditary instructions for building, running and maintaining an organism, and passing life on to the next generation. The genome is comprised of DNA (deoxyribonucleic acid), which encodes genes. Genes coordinately determine specific characteristics of the organism. Each species has its own distinctive genome, whether it is a plant or animal, bacteria or virus, mammal or reptile (e.g., the dog genome, the wheat genome, the rat genome, the herpes virus genome, the Escherichia coli (E. coli) genome, the budding yeast genome and so on). The genome contains all of the information necessary to produce a specific organism. Genomes belong to species, but they also belong to individuals. Only identical twins and other clones have the exact same genome. The genes of an organism whether an animal, plant or microbe determine its physical and chemical characteristics. Genes consist of organized units of DNA; these units of DNA are comprised of four different chemical bases called nucleotides. In the double helical structure of DNA, each nucleotide unit pairs with its complementary nucleotide forming a base pair. Only certain pairs of nucleotide bases can form these bonds: cytosine (C) always pairs with guanine (G) and adenine (A) always pairs with thymine (T). When two DNA strands are complementary, they can bind together to form a double helix in a process called hybridization. DNA, and specifically the sequence of the C, G, A and T nucleotides along the DNA strand in each gene, lays out the blueprint or instruction program for biological organisms. In addition to genes, there are much smaller regulatory sequences (usually ten to 20 letters long) that may be associated with each gene and are used by cells to control when and how much of the gene should be produced. The genomes of more evolved organisms may contain a large amount of junk DNA that is left over from the process of evolution. The precise sequence of the nucleotides in a gene dictates the physical and chemical properties of the protein the gene encodes. The activity of these proteins causes the cell to perform biological functions that influence the physical traits of the organism. Each cell of an organism contains at least one complete copy of the organism s genes, but each cell type expresses only those genes that are necessary for that particular cell to perform its role. When a gene is expressed, it acts alone or in combination with other expressed genes to synthesize structural proteins and enzymes. A modification in a gene sequence may lead to the overproduction or underproduction of a protein, modifying the normal biological function of the cell, and potentially affecting the physical and chemical characteristics of the entire organism TriMark Publications, LLC. All rights reserved. 9
10 1.6 Gene Expression Cells carry out their normal biological functions through the genetic instructions encoded in their DNA. This genetic process, known as gene expression, involves several steps. In the first step, nucleotides in a gene are copied into a related nucleic acid molecule called ribonucleic acid (RNA), specifically, messenger RNA (mrna). Cells translate RNA into proteins, and proteins are the biological end products that regulate or perform most of the physiological functions of the body. Because the order, or sequence, of nucleotides in each gene is different, each gene directs the production of a different protein. Increased awareness of the role of genes in regulating the functions of living organisms has generated a worldwide effort to identify and sequence genes and genomes of many organisms. This effort was led by the Human Genome Project (HGP) and also involved academic, government and industry research projects, and was essentially completed in 2003 with the sequencing of 99% of the human genome. Ongoing sequencing and analysis indicated in 2004 that there are 25,000 to 30,000 protein-coding genes in the human genome. In 2006, the complete sequence of the last human chromosome was published. It is anticipated that many years of additional research will be required to understand the specific functions and roles in disease of each of these genes and their patterns of interaction. This research is expected to lead to a new healthcare paradigm, in which a disease is understood at the molecular level, allowing patients to be diagnosed according to their genetic profile and treated accordingly with drugs designed to work on specific molecular targets. In addition to diagnosis and treatment, genetic information may ultimately lead to novel therapies for preventing or curing disease. 1.7 Genetic Variability The diversity of living organisms results from variability in their genomes. Variability stems from differences in the sequences of genes and from differences in levels of gene expression, partly because of interaction of the organism and its genes with the environment. In order to understand how genetic variation causes disease, scientists must compare both sequence variation and expression patterns of genes from healthy and diseased individuals. Chip-array technology has simplified, accelerated and reduced the cost of analyzing genetic variability, and has lead to new opportunities in disease management. Sequence Variability Changes in the sequences of genes may be introduced by environmental factors or other determinants, such as errors in gene replication. These sequence changes are known as polymorphisms and can be passed from generation to generation. In some cases, polymorphisms have no detectable effect on the biology of the organism. However, in other cases, polymorphisms can result in the altered function or expression of the protein encoded by the gene. Such polymorphisms are normally referred to as mutations. Mutations in single genes have been associated with diseases such as cystic fibrosis and sickle cell anemia, while mutations in multiple genes have been associated with diseases such as cancer and diabetes. By screening for polymorphisms, researchers seek to correlate variability in the sequence of genes with a specific disease. By sequencing genes of interest from a large number of healthy and diseased persons, researchers are able to correlate specific gene polymorphisms with the disease. However, a typical polymorphism association project on one disease might require sequencing 100 genes of 3,000 nucleotide bases each in up to 500 patients, or a total of 150 million bases. Previously, such high-volume polymorphism screening was performed with gel-based sequencing, which was labor intensive and costly. Currently, chip-array technology is used and has many advantages over conventional, gel-based techniques for performing large studies in genetic correlation. Chips enable high-throughput polymorphism discovery and database projects, as well as product development initiatives to allow researchers to identify correlations between disease and genomic changes. Expression Variability Differences in the timing and levels of gene expression in a given cell are another basis for genetic variability. Although most cells contain an organism s full set of genes, each cell expresses only a small fraction of this set in different quantities and at different times. The expression of genes at the wrong time, the expression of a gene mutation, or the overexpression or underexpression of normal genes have all been associated with human diseases 2008 TriMark Publications, LLC. All rights reserved. 10
GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE)
TriMark Publications April 2007 Volume: TMRGER07-0401 GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS
More information(SAMPLE COPY, NOT FOR RESALE)
TriMark Publications May 2011 Volume: TMREMI11-0501 EUROPEAN MEDICAL IMAGING MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS
More informationBayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms
Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms Genomics Bioinformatics HTS Combinatorial chemistry Protein drugs
More informationTable of Contents. Introduction. Global Market Trends and Emerging Technologies. A. DNA Sequencing. B. DNA and RNA Probe Technology
European Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape Introduction Table of Contents Global Market
More informationMICROARRAYS: CHIPPING AWAY AT THE MYSTERIES OF SCIENCE AND MEDICINE
MICROARRAYS: CHIPPING AWAY AT THE MYSTERIES OF SCIENCE AND MEDICINE National Center for Biotechnology Information With only a few exceptions, every
More informationPioneering Clinical Omics
Pioneering Clinical Omics Clinical Genomics Strand NGS An analysis tool for data generated by cutting-edge Next Generation Sequencing(NGS) instruments. Strand NGS enables read alignment and analysis of
More informationGenomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Increasing usage of novel genomics techniques and tools, evaluation of their benefit to patient outcome and focusing
More informationLesson Overview. Studying the Human Genome. Lesson Overview Studying the Human Genome
Lesson Overview 14.3 Studying the Human Genome THINK ABOUT IT Just a few decades ago, computers were gigantic machines found only in laboratories and universities. Today, many of us carry small, powerful
More informationDNA and Biotechnology Form of DNA Form of DNA Form of DNA Form of DNA Replication of DNA Replication of DNA
21 DNA and Biotechnology DNA and Biotechnology OUTLINE: Replication of DNA Gene Expression Mutations Regulating Gene Activity Genetic Engineering Genomics DNA (deoxyribonucleic acid) Double-stranded molecule
More informationAGRO/ANSC/BIO/GENE/HORT 305 Fall, 2016 Overview of Genetics Lecture outline (Chpt 1, Genetics by Brooker) #1
AGRO/ANSC/BIO/GENE/HORT 305 Fall, 2016 Overview of Genetics Lecture outline (Chpt 1, Genetics by Brooker) #1 - Genetics: Progress from Mendel to DNA: Gregor Mendel, in the mid 19 th century provided the
More informationFollowing text taken from Suresh Kumar. Bioinformatics Web - Comprehensive educational resource on Bioinformatics. 6th May.2005
Bioinformatics is the recording, annotation, storage, analysis, and searching/retrieval of nucleic acid sequence (genes and RNAs), protein sequence and structural information. This includes databases of
More informationFuture of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities
Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities Introduction The report analyzes current and potential world molecular diagnostics markets and advances in the field.
More informationChapter 15 Gene Technologies and Human Applications
Chapter Outline Chapter 15 Gene Technologies and Human Applications Section 1: The Human Genome KEY IDEAS > Why is the Human Genome Project so important? > How do genomics and gene technologies affect
More informationDNA/RNA MICROARRAYS NOTE: USE THIS KIT WITHIN 6 MONTHS OF RECEIPT.
DNA/RNA MICROARRAYS This protocol is based on the EDVOTEK protocol DNA/RNA Microarrays. 10 groups of students NOTE: USE THIS KIT WITHIN 6 MONTHS OF RECEIPT. 1. EXPERIMENT OBJECTIVE The objective of this
More informationPOLYMERASE CHAIN REACTION (PCR) TECHNOLOGIES AND GLOBAL MARKETS
POLYMERASE CHAIN REACTION (PCR) TECHNOLOGIES AND GLOBAL MARKETS BIO087B March 2014 Jackson Highsmith Project Analyst ISBN: 1-56965-742-4 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA
More informationStudying the Human Genome. Lesson Overview. Lesson Overview Studying the Human Genome
Lesson Overview 14.3 Studying the Human Genome THINK ABOUT IT Just a few decades ago, computers were gigantic machines found only in laboratories and universities. Today, many of us carry small, powerful
More informationFrumkin, 2e Part 1: Methods and Paradigms. Chapter 6: Genetics and Environmental Health
Frumkin, 2e Part 1: Methods and Paradigms Chapter 6: Genetics and Environmental Health Genetics Genetics, the study of individual genes, has expanded to include genomics, which is the study of all the
More informationTECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298
DIAGNOSTICS BUSINESS ANALYSIS SERIES: TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 By ADAMS BUSINESS ASSOCIATES March 2017. March 2017 ABA 298 1 Technologies, Products & Services
More informationUNIT MOLECULAR GENETICS AND BIOTECHNOLOGY
UNIT MOLECULAR GENETICS AND BIOTECHNOLOGY Standard B-4: The student will demonstrate an understanding of the molecular basis of heredity. B-4.1-4,8,9 Effective June 2008 All Indicators in Standard B-4
More informationCellular Assays. A Strategic Market Analysis. Sample Slides
A Strategic Market Analysis Sample Slides 2002 For information contact: Frontline Strategic Consulting, Inc. 1065 E. Hillsdale Blvd, Suite 403, Foster City, CA 94404 650-525-1500 x125, x135 or x145 info@frontlinesmc.com
More informationExome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome.
Glossary of Terms Genetics is a term that refers to the study of genes and their role in inheritance the way certain traits are passed down from one generation to another. Genomics is the study of all
More informationBiomarkers in Biochips and Microarrays: Innovative Technologies, Growth Opportunities and Future Market Outlook
Biomarkers in Biochips and Microarrays: Innovative Technologies, Growth Opportunities and Future Market Outlook Introduction The report provides a strategic insight into the use of biomarkers in biochip
More informationBasic Information. I.1 If your company performs biotechnology research and development, uses a. The Categories of Biotechnology Applications.
APPENDIX 2 SURVEY QUESTIONNAIRE Part I. Basic Information I.1 If your company performs biotechnology research and development, uses a biotechnology process in manufacturing, or produces research tools,
More informationPharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001
Pharmacogenetics: A SNPshot of the Future Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 1 I. What is pharmacogenetics? It is the study of how genetic variation affects drug response
More informationGenetics 101. Prepared by: James J. Messina, Ph.D., CCMHC, NCC, DCMHS Assistant Professor, Troy University, Tampa Bay Site
Genetics 101 Prepared by: James J. Messina, Ph.D., CCMHC, NCC, DCMHS Assistant Professor, Troy University, Tampa Bay Site Before we get started! Genetics 101 Additional Resources http://www.genetichealth.com/
More informationE2ES to Accelerate Next-Generation Genome Analysis in Clinical Research
www.hcltech.com E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution
More informationChapter 10 Genetic Engineering: A Revolution in Molecular Biology
Chapter 10 Genetic Engineering: A Revolution in Molecular Biology Genetic Engineering Direct, deliberate modification of an organism s genome bioengineering Biotechnology use of an organism s biochemical
More informationConcepts of Genetics, 10e (Klug/Cummings/Spencer/Palladino) Chapter 1 Introduction to Genetics
1 Concepts of Genetics, 10e (Klug/Cummings/Spencer/Palladino) Chapter 1 Introduction to Genetics 1) What is the name of the company or institution that has access to the health, genealogical, and genetic
More informationPresidential Commission for the Study of Bioethical Issues 2 nd meeting September
Presidential Commission for the Study of Bioethical Issues 2 nd meeting September 13 14 2010 David B. Weiner, Ph.D. Professor Department of Pathology and Laboratory Medicine University of Pennsylvania
More informationIntroduction to BioMEMS & Medical Microdevices DNA Microarrays and Lab-on-a-Chip Methods
Introduction to BioMEMS & Medical Microdevices DNA Microarrays and Lab-on-a-Chip Methods Companion lecture to the textbook: Fundamentals of BioMEMS and Medical Microdevices, by Prof., http://saliterman.umn.edu/
More informationSTUDY GUIDE SECTION 13-1 DNA Technology
STUDY GUIDE SECTION 13-1 DNA Technology Name Period Date Multiple Choice-Write the correct letter in the blank. 1. To cut DNA molecules into pieces at specific sequences of nucleotides, genetic engineers
More informationDeoxyribonucleic Acid DNA
Introduction to BioMEMS & Medical Microdevices DNA Microarrays and Lab-on-a-Chip Methods Companion lecture to the textbook: Fundamentals of BioMEMS and Medical Microdevices, by Prof., http://saliterman.umn.edu/
More informationBiotechnology: DNA Technology & Genomics
Chapter 20. Biotechnology: DNA Technology & Genomics 2003-2004 1 The BIG Questions! How can we use our knowledge of DNA to: " diagnose disease or defect? " cure disease or defect? " change/improve organisms?!
More informationVisit our Career Flowchart to get more information on some of these career paths.
Visit our Career Flowchart to get more information on some of these career paths. Academic Research Faculty: This career path consists of university or college professors who conduct research. They select
More informationWhat Are the Chemical Structures and Functions of Nucleic Acids?
THE NUCLEIC ACIDS What Are the Chemical Structures and Functions of Nucleic Acids? Nucleic acids are polymers specialized for the storage, transmission, and use of genetic information. DNA = deoxyribonucleic
More informationCentre for NanoHealth
Steve Conlan PhD An integrated collaborative base for businesses in Wales Director - Reproductive Biology & Cancer Research Institute of Life Science School of Medicine Unique interdisciplinary R&D environment,
More informationGenetics and Biotechnology. Section 1. Applied Genetics
Section 1 Applied Genetics Selective Breeding! The process by which desired traits of certain plants and animals are selected and passed on to their future generations is called selective breeding. Section
More informationAlgorithms in Bioinformatics ONE Transcription Translation
Algorithms in Bioinformatics ONE Transcription Translation Sami Khuri Department of Computer Science San José State University sami.khuri@sjsu.edu Biology Review DNA RNA Proteins Central Dogma Transcription
More informationMolecular Biology. IMBB 2017 RAB, Kigali - Rwanda May 02 13, Francesca Stomeo
Molecular Biology IMBB 2017 RAB, Kigali - Rwanda May 02 13, 2017 Francesca Stomeo Molecular biology is the study of biology at a molecular level, especially DNA and RNA - replication, transcription, translation,
More informationDNA & THE GENETIC CODE DON T PANIC! THIS SECTION OF SLIDES IS AVAILABLE AT CLASS WEBSITE
DNA & THE GENETIC CODE DON T PANIC! THIS SECTION OF SLIDES IS AVAILABLE AT CLASS WEBSITE Recommended reading: The Double Helix: A Personal Account of the Discovery of the Structure of DNA, by James D.
More informationChapter 13 - Concept Mapping
Chapter 13 - Concept Mapping Using the terms and phrases provided below, complete the concept map showing the discovery of DNA structure. amount of base pairs five-carbon sugar purine DNA polymerases Franklin
More informationGenomes contain all of the information needed for an organism to grow and survive.
Section 3: Genomes contain all of the information needed for an organism to grow and survive. K What I Know W What I Want to Find Out L What I Learned Essential Questions What are the components of the
More informationBIOTECH 101 UNDERSTANDING THE BASICS
BIOTECH 101 UNDERSTANDING THE BASICS Genetics is at the forefront of investigations into human variation, disease and biotechnology. Newspapers, TV, magazines, radio and the internet have made genetics
More informationCHAPTERS 16 & 17: DNA Technology
CHAPTERS 16 & 17: DNA Technology 1. What is the function of restriction enzymes in bacteria? 2. How do bacteria protect their DNA from the effects of the restriction enzymes? 3. How do biologists make
More informationDNA Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast,
DNA Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013-2019 The completion of human genome project resulted in discovery of several human disease causing genes.
More informationLecture #1. Introduction to microarray technology
Lecture #1 Introduction to microarray technology Outline General purpose Microarray assay concept Basic microarray experimental process cdna/two channel arrays Oligonucleotide arrays Exon arrays Comparing
More informationThe Computational Impact of Genomics on Biotechnology R&D (sort of )
The Computational Impact of Genomics on Biotechnology R&D (sort of ) John Scooter Morris, Ph.D. Genentech, Inc. November 13, 2001 page 1 Biotechnology? Means many things to many people Genomics Gene therapy
More informationTotal genomic solutions for biobanks. Maximizing the value of your specimens.
Total genomic solutions for biobanks. Maximizing the value of your specimens. Unlock the true potential of your biological samples. Greater understanding. Increased value. Value-driven biobanking. Now
More informationAlgorithms in Bioinformatics
Algorithms in Bioinformatics Sami Khuri Department of Computer Science San José State University San José, California, USA khuri@cs.sjsu.edu www.cs.sjsu.edu/faculty/khuri Outline Central Dogma of Molecular
More informationCourse Agenda. Day One
Course Agenda BioImmersion: Biotech for the Non-Scientist A three-day, in-depth course that provides the background required for understanding today s fast-paced biotech marketplace. Beginning with an
More informationSubmission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008
(Previously Oxford NanoLabs) Genomic Medicine Submission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008 Introduction Oxford Nanopore Technologies
More informationGenetic tests are available for hundreds of disorders. DNA testing can pinpoint the exact genetic basis of a disorder.
Human DNA Analysis Human DNA Analysis There are roughly 6 billion base pairs in your DNA. Biologists search the human genome using sequences of DNA bases. Genetic tests are available for hundreds of disorders.
More informationTerritory Account Manager (MD, NC or TX based)
Territory Account Manager (MD, NC or TX based) Looking for bilingual Chinese-English young professionals with passion in selling genomics services. The Territory Account Manager's role is to ensure achievement
More information1-Microbial Taxonomy: classification nomenclature identification
Part 1 Basic Medical Microbiology 1-Microbial Taxonomy: Taxonomy is the area of biologic science comprising three distinct, but highly interrelated, disciplines that include classification, nomenclature,
More informationCAP BIOINFORMATICS Su-Shing Chen CISE. 10/5/2005 Su-Shing Chen, CISE 1
CAP 5510-9 BIOINFORMATICS Su-Shing Chen CISE 10/5/2005 Su-Shing Chen, CISE 1 Basic BioTech Processes Hybridization PCR Southern blotting (spot or stain) 10/5/2005 Su-Shing Chen, CISE 2 10/5/2005 Su-Shing
More informationMolecular Diagnostics: Market Segmentation and Opportunities
Molecular Diagnostics: Market Segmentation and Opportunities October 2010 This market report is published by DeciBio, LLC. All rights reserved. Reproduction or redistribution of this report in any form
More informationDNA & DNA Replication
DNA & DNA Replication DNA Structure How did Watson and Crick contribute to our understanding of genetics? Watson and Crick developed the double helix model for DNA DNA Structure What is a double helix?
More information2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award
2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award 2018 2018 NORTH AMERICAN REAL-WORLD EVIDENCE ENTERPRISE SOLUTIONS MARKET LEADERSHIP AWARD Contents Background and Company
More informationQiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review
Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports from
More informationMotivation From Protein to Gene
MOLECULAR BIOLOGY 2003-4 Topic B Recombinant DNA -principles and tools Construct a library - what for, how Major techniques +principles Bioinformatics - in brief Chapter 7 (MCB) 1 Motivation From Protein
More informationDepartment of Genetics
Department of Genetics Program Specific Outcomes (PSO) Program- MSc. Genetics (404) The course prepares students for pursuing further research and teaching. Key features: Students have high success rate
More informationBUILDING BETTER SCIENCE
BUILDING BETTER SCIENCE AGILENT AND YOU ACADEMIC & INSTITUTIONAL RESEARCH ENRICH DISCOVER SUPPORT STIMULATE AGILENT IN ACADEMIA: DRIVEN TO CONNECT Academia is a highly interactive and interdisciplinary
More informationClass XII Chapter 6 Molecular Basis of Inheritance Biology
Question 1: Group the following as nitrogenous bases and nucleosides: Adenine, Cytidine, Thymine, Guanosine, Uracil and Cytosine. Nitrogenous bases present in the list are adenine, thymine, uracil, and
More informationMolecular Basis of Inheritance
Molecular Basis of Inheritance Question 1: Group the following as nitrogenous bases and nucleosides: Adenine, Cytidine, Thymine, Guanosine, Uracil and Cytosine. Answer Nitrogenous bases present in the
More informationVertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis
Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis -Collaboration to explore use of mrna Therapeutics to treat the underlying cause of CF
More informationCapabilities & Services
Capabilities & Services Accelerating Research & Development Table of Contents Introduction to DHMRI 3 Services and Capabilites: Genomics 4 Proteomics & Protein Characterization 5 Metabolomics 6 In Vitro
More informationChapter 6. Genes and DNA. Table of Contents. Section 1 What Does DNA Look Like? Section 2 How DNA Works
Genes and DNA Table of Contents Section 1 What Does DNA Look Like? Section 1 What Does DNA Look Like? Objectives List three important events that led to understanding the structure of DNA. Describe the
More informationAGENDA for 10/11/13 AGENDA: HOMEWORK: Due end of the period OBJECTIVES:
AGENDA for 10/11/13 AGENDA: 1. Finish 1.2.3 DNA Analysis Analyzing DNA Samples Using Current Forensic Methods OBJECTIVES: 1. Demonstrate the steps of gel electrophoresis 2. Analyze restriction fragment
More informationIntroduction to Bioinformatics
Introduction to Bioinformatics Contents Cell biology Organisms and cells Building blocks of cells How genes encode proteins? Bioinformatics What is bioinformatics? Practical applications Tools and databases
More informationLecture Overview. Overview of the Genetic Information. Chapter 3 DNA & RNA Lecture 6
Visual Anatomy & Physiology First Edition Martini & Ober Chapter 3 DNA & RNA Lecture 6 Lecture Overview What is the cell s genetic information? How/where is the genetic information stored in eukaryotic
More informationWeek 1: Discovery Biology Basic knowledge and tools used in Research and Development
Downing - Keio Summer School 2018 Healthcare and Biotechnology Course Outline page 1 Strand A: Healthcare and Biotechnology Course Outline This course aims to provide an overview of the current challenges
More informationMolecular Diagnostics
Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R
More informationBIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS
: TECHNOLOGIES AND GLOBAL MARKETS BIO061C April 2014 Jackson Highsmith Project Analyst ISBN: 1-56965-801-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within
More informationThe study of the structure, function, and interaction of cellular proteins is called. A) bioinformatics B) haplotypics C) genomics D) proteomics
Human Biology, 12e (Mader / Windelspecht) Chapter 21 DNA Which of the following is not a component of a DNA molecule? A) a nitrogen-containing base B) deoxyribose sugar C) phosphate D) phospholipid Messenger
More informationPersonalised Medicine Regulatory Issues
Personalised Medicine Regulatory Issues INFRAFRONTIER / IMPC Stakeholder Meeting Presented by Marisa Papaluca on 14 November 2017 Senior Scientific Advisor, Scientific Committees Regulatory Science Strategy
More informationComplex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine
Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine January 18, 2013 Anna D. Barker, Ph.D. Director, Transformative Healthcare Networks C-Director, Complex Adaptive Systems Initiative
More informationSemi-conservative replication DNA Helicases DNA polymerases Transcription Codon Messenger RNA Transfer RNA. Molecular Genetics Unit
Name: Unit 7 Molecular Genetics Students will be able to: Theme: DNA Heredity 6.1 Understand the structure and role of DNA Explain the structure of DNA (monomer and polymer) Discuss the process of DNA
More informationGeneration of research tools to translate genomic discoveries into drug discovery projects. Nils Ostermann, Novartis
Generation of research tools to translate genomic discoveries into drug discovery projects Nils Ostermann, Novartis Need for public-private collaboration Common interest Genomic information is growing
More informationBusiness and Industry Advisory Committee to the OECD - Comité Consultatif Economique et Industriel Auprès de l OCDE
Business and Industry Advisory Committee to the OECD - Comité Consultatif Economique et Industriel Auprès de l OCDE In Committee BIOTECHNOLOGY: A KEY CONTRIBUTOR TO SUSTAINABLE ECONOMIC GROWTH A Vision
More informationKonica Minolta to Acquire Invicro (US)
Konica Minolta to Acquire Invicro (US) Acceleration of expansion of precision medicine business Offering new value for drug discovery and development in immuno-oncology and neurodegenerative disease September
More informationDNA and RNA Structure. Unit 7 Lesson 1
Unit 7 Lesson 1 Students will be able to: Explain the structure and function of the DNA and RNA. Illustrate the structure of nucleotide. Summarize the differences between DNA and RNA. Identify the different
More informationSTRAND NGS 3.0 ALLOWS USERS TO ANALYZE DATA AT NEARLY TWICE THE SPEED
bio chat STRAND NGS 3.0 ALLOWS USERS TO ANALYZE DATA AT NEARLY TWICE THE SPEED The Bangalore based Strand Life Sciences has been recently in news for the back to back launch of two innovative products.
More informationII. DNA Deoxyribonucleic Acid Located in the nucleus of the cell Codes for your genes Frank Griffith- discovered DNA in 1928
HEREDITY = passing on of characteristics from parents to offspring I. DNA, Chromosomes, Chromatin, and Genes DNA = blueprint of life (has the instructions for making an organism) Chromatin= uncoiled DNA
More informationPersonalised medicine: paradigm shift in the pharma business
Personalised medicine: paradigm shift in the pharma business This text first appeared in the IAM magazine supplement IP Value in the life sciences industries February 2006 For further information please
More informationPresentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development
Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development 23 November 2009 Sharon F. Terry, MA President & CEO, Genetic Alliance Executive Director, PXE International
More informationAGENDA for 10/10/13 AGENDA: HOMEWORK: Due end of the period OBJECTIVES: Due Fri, 10-11
AGENDA for 10/10/13 AGENDA: 1. 1.2.3 DNA Analysis Analyzing DNA Samples Using Current Forensic Methods OBJECTIVES: 1. Demonstrate the steps of gel electrophoresis 2. Analyze restriction fragment length
More informationDelivering on the Promise of Precision Medicine
Delivering on the Promise of Precision Medicine Bay Area Council Economic Institute Spring 2016 The Promise of Precision Medicine The Bay Area is one of the world s biggest hubs for innovation in research
More informationIntroduction to Bioinformatics
Introduction to Bioinformatics If the 19 th century was the century of chemistry and 20 th century was the century of physic, the 21 st century promises to be the century of biology...professor Dr. Satoru
More informationBiotechnology Chapter 20
Biotechnology Chapter 20 DNA Cloning DNA Cloning AKA Plasmid-based transformation or molecular cloning First off-let s sum up what happens. A plasmid is taken from a bacteria A gene is inserted into the
More informationUnit 3c. Microbial Gene0cs
Unit 3c Microbial Gene0cs Microbial Genetics! Gene0cs: the science of heredity Genome: the gene0c informa0on in the cell Genomics: the sequencing and molecular characteriza0on of genomes Gregor Mendel
More informationHuman Genomics. 1 P a g e
Human Genomics What were the aims of the human genome project? To identify all the approximately 20,000-25,000 genes in Human DNA. To find where each gene is located To determine the sequences of the 3
More informationChapter 11 Quiz #8: February 13 th You will distinguish between the famous scientists and their contributions towards DNA You will demonstrate replication, transcription, and translation from a sample
More informationInvesting in Discovery
Investing in Discovery The Impact of Basic Research and the Role of the National Institute of General Medical Sciences Jeremy M. Berg, Ph.D. Director National Institute of General Medical Sciences National
More informationWhat happens after DNA Replication??? Transcription, translation, gene expression/protein synthesis!!!!
What happens after DNA Replication??? Transcription, translation, gene expression/protein synthesis!!!! Protein Synthesis/Gene Expression Why do we need to make proteins? To build parts for our body as
More informationPersonalized Human Genome Sequencing
Personalized Human Genome Sequencing Dr. Stefan Platz DABT, Global Head Drug Safety & Metabolism Biomedical research: strengths & limitations of non-animal alternatives 06 December 2016 The Human Genome
More informationMolecular Probes. Mitesh Shrestha
Molecular Probes Mitesh Shrestha Molecular Probes Small DNA segments (genomic DNA, cdna or synthetic oligonucleotides) or RNA segments (often synthesized on DNA template) that recognize complementary sequences
More informationPartnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC To Our Potential Partners We offer partners the depth of
More informationProteomics: New Discipline, New Resources. Fred Stoss, University at Buffalo, NERM 2004, Rochester, NY
Proteomics: New Discipline, New Resources Fred Stoss, University at Buffalo, NERM 2004, Rochester, NY What is Proteomics? Systematic analysis of protein expression of normal and diseased tissues that involves
More informationInnovative Medicines Initiative
Innovative Medicines Initiative EMA - EBE Regulatory Conference on ATMPs Salah-Dine Chibout, Novartis Global Head Discovery & Investigative Safety/ Global Head Preclinical Safety Therapeutic Areas IMI
More informationCan Semantic Web Technologies enable Translational Medicine? (Or Can Translational Medicine help enrich the Semantic Web?)
Can Semantic Web Technologies enable Translational Medicine? (Or Can Translational Medicine help enrich the Semantic Web?) Vipul Kashyap 1, Tonya Hongsermeier 1, Samuel Aronson 2 1 Clinical Informatics
More information